SUPPRESS

Shares of Chimerix Inc (NASDAQ: CMRX) were halted at around 7:25 a.m. ET on Monday. Chimerix, a biopharmaceutical company that develops antivirals in areas of high unmet medical need, announced in a press release that a Phase 3 study for its SUPPRESS of brincidofovir in patients undergoing...